Health
New gene-based vaccine strategy receives grant from the Bill & Melinda Gates Foundation – News-Medical.Net
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million…
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation.
The grant will aid the effort to bring further preclinical validation to the AAV vaccine platform. An AAVCOVID vaccine candidate is set to enter clinical trials in 2021.
The AAVCOVID vaccine program was founded at Mass General Brigham at the outset of the pandemic.
Preliminary tests of the vaccines’…
-
General20 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General23 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News22 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business20 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher